|
Atomistry » Chlorine » PDB 4n9a-4ngr » 4ncg | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atomistry » Chlorine » PDB 4n9a-4ngr » 4ncg » |
Chlorine in PDB 4ncg: Discovery of Doravirine, An Orally Bioavailable Non-Nucleoside Reverse Transcriptase Inhibitor Potent Against A Wide Range of Resistant Mutant Hiv VirusesEnzymatic activity of Discovery of Doravirine, An Orally Bioavailable Non-Nucleoside Reverse Transcriptase Inhibitor Potent Against A Wide Range of Resistant Mutant Hiv Viruses
All present enzymatic activity of Discovery of Doravirine, An Orally Bioavailable Non-Nucleoside Reverse Transcriptase Inhibitor Potent Against A Wide Range of Resistant Mutant Hiv Viruses:
2.7.7.49; 2.7.7.7; 3.1.13.2; 3.1.26.13; Protein crystallography data
The structure of Discovery of Doravirine, An Orally Bioavailable Non-Nucleoside Reverse Transcriptase Inhibitor Potent Against A Wide Range of Resistant Mutant Hiv Viruses, PDB code: 4ncg
was solved by
Y.Yan,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Other elements in 4ncg:
The structure of Discovery of Doravirine, An Orally Bioavailable Non-Nucleoside Reverse Transcriptase Inhibitor Potent Against A Wide Range of Resistant Mutant Hiv Viruses also contains other interesting chemical elements:
Chlorine Binding Sites:
The binding sites of Chlorine atom in the Discovery of Doravirine, An Orally Bioavailable Non-Nucleoside Reverse Transcriptase Inhibitor Potent Against A Wide Range of Resistant Mutant Hiv Viruses
(pdb code 4ncg). This binding sites where shown within
5.0 Angstroms radius around Chlorine atom.
In total only one binding site of Chlorine was determined in the Discovery of Doravirine, An Orally Bioavailable Non-Nucleoside Reverse Transcriptase Inhibitor Potent Against A Wide Range of Resistant Mutant Hiv Viruses, PDB code: 4ncg: Chlorine binding site 1 out of 1 in 4ncgGo back to![]() ![]()
Chlorine binding site 1 out
of 1 in the Discovery of Doravirine, An Orally Bioavailable Non-Nucleoside Reverse Transcriptase Inhibitor Potent Against A Wide Range of Resistant Mutant Hiv Viruses
![]() Mono view ![]() Stereo pair view
Reference:
B.Cote,
J.D.Burch,
E.Asante-Appiah,
C.Bayly,
L.Bedard,
M.Blouin,
L.C.Campeau,
E.Cauchon,
M.Chan,
A.Chefson,
N.Coulombe,
W.Cromlish,
S.Debnath,
D.Deschenes,
K.Dupont-Gaudet,
J.P.Falgueyret,
R.Forget,
S.Gagne,
D.Gauvreau,
M.Girardin,
S.Guiral,
E.Langlois,
C.S.Li,
N.Nguyen,
R.Papp,
S.Plamondon,
A.Roy,
S.Roy,
R.Seliniotakis,
M.St-Onge,
S.Ouellet,
P.Tawa,
J.F.Truchon,
J.Vacca,
M.Wrona,
Y.Yan,
Y.Ducharme.
Discovery of Mk-1439, An Orally Bioavailable Non-Nucleoside Reverse Transcriptase Inhibitor Potent Against A Wide Range of Resistant Mutant Hiv Viruses. Bioorg.Med.Chem.Lett. V. 24 917 2014.
Page generated: Fri Jul 11 19:33:49 2025
ISSN: ISSN 0960-894X PubMed: 24412110 DOI: 10.1016/J.BMCL.2013.12.070 |
Last articlesFe in 2YXOFe in 2YRS Fe in 2YXC Fe in 2YNM Fe in 2YVJ Fe in 2YP1 Fe in 2YU2 Fe in 2YU1 Fe in 2YQB Fe in 2YOO |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |